Lilly Turns From One Company Veteran to Another for New CEOBy and
Ricks has led medicines unit, held M&A and marketing roles
Lechleiter started as organic chemist at drugmaker in 1979
Over the last eight years, Eli Lilly & Co. relied on a three-decade company veteran to steer it through declining sales and a struggling product pipeline. Now it’s turned to another long-time executive for its next chapter.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.